Recently Featured

FDA Launches Pilot Program to Accelerate Drug Testing Approvals

October 3, 2026
WASHINGTON — The Food and Drug Administration is now accepting applications for a new pilot program aimed at significantly reducing the time required for drug manufacturers to initiate human testing of their products, as announced on Tuesday. This initiative, which was initially revealed in June, is part of Operation TrialBlazer, a broader effort by the…

FDA Launches Pilot Program to Accelerate Early Drug Research in the U.S.

October 3, 2026
First teased in June and formally announced Tuesday as part of “Operation Trialblazer,” the program will partner drugmakers with research institutions to more quickly bring medicines into human testing. This initiative aims to streamline the often protracted process of early-stage clinical trials, which can delay the introduction of potentially life-saving therapies to the market. The…

Standout pharma marketing takes the stage at the 2026 Fierce Pharma Marketing Awards

October 2, 2026
The 2026 Fierce Pharma Marketing Awards highlighted the achievements of leading pharmaceutical companies, with GSK, Novartis, and argenx among the notable winners across 20 different categories. This event underscores the growing importance of innovative marketing strategies in a highly competitive landscape, where effective communication can significantly influence market positioning and stakeholder engagement. As the pharmaceutical…

Buried knowledge could cost pharma billions. Here’s how to fix it

October 2, 2026
A global pharmaceutical company already has the competitive report it needs. The problem is that the report is buried somewhere within the organisation’s information stores, and the marketing specialist who needs it cannot find it. They spend the next two days recreating work that someone else completed months earlier. What began as a knowledge-access issue…

Ongoing Cases